World Vaccine Congress Europe 2024

이벤트:

Join Novotech at the World Vaccine Congress, October 29-31, 2024, in Barcelona, Spain, where global leaders in vaccine R&D will collaborate to drive innovation.

With extensive global expertise across more than 4,000 clinical projects, spanning Phase I-IV and bioequivalence studies, Novotech’s Vaccine-Specific Operating Model is designed to accelerate study startup and execution, ensuring speed and efficiency for your vaccine trials.

Schedule a meeting with our experts, Jan Rezulski, Director of Business Development, and Nikki Miller, Senior Therapeutic Strategy Manager, directly through the event networking app. Don't miss the opportunity to connect with us in Barcelona!

Nikki will also be presenting alongside Brayden Fraser, Chief Development Officer, Emeritus Research on the topic "Rapid Vaccine Solutions — Selecting Australia as a Location for Vaccine Clinical Trials."

We look forward to exploring how Novotech can support your vaccine clinical development needs.